Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2003
09/10/2003EP1342477A1 Cationic vehicle: dna complexes and their use in gene therapy
09/10/2003EP1342476A2 FGFR3 as a marker for mesenchymal skeletal progenitor cells and use of cytotoxic conjugates comprising an FGFR3 binding agent for the treatment of cartilagineous bony tumours
09/10/2003EP1342474A1 The use of proline, poly-proline peptides and proline-rich proteins to quench reactive oxygen species
09/10/2003EP1342469A2 Stable glass state powder formulations
09/10/2003EP1342410A2 Transgenic animals lacking a functional galanin gene
09/10/2003EP1342084A2 Assay for anti-viral agent
09/10/2003EP1341930A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human adult liver
09/10/2003EP1341929A2 Fen endonucleases
09/10/2003EP1341923A2 Methods for enhancing the efficacy of cancer therapy
09/10/2003EP1341921A2 Hydrolases
09/10/2003EP1341920A2 Human elongase genes and uses thereof
09/10/2003EP1341917A2 26199, 33530, 33949, 47148, 50226, and 58764, human transferase family members and uses therefor
09/10/2003EP1341914A2 Regulation of angiogenesis with zinc finger proteins
09/10/2003EP1341909A2 A method for in vitro molecular evolution of protein function
09/10/2003EP1341908A2 Targeted enzyme prodrug therapy
09/10/2003EP1341907A2 Target enzymes
09/10/2003EP1341905A2 Tec kinase assay
09/10/2003EP1341904A1 Zipper protein kinase and uses thereof
09/10/2003EP1341819A2 Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament
09/10/2003EP1341817A2 Tff peptides
09/10/2003EP1341816A2 Peptides derived from colostrinin
09/10/2003EP1341814A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/10/2003EP1341811A2 Orally ingestible preparation of mistletoe lectins and method
09/10/2003EP1341809A2 Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test
09/10/2003EP1341807A2 Interferon-alpha induced gene
09/10/2003EP1341803A2 Novel nucleic acids and polypeptides
09/10/2003EP1341767A2 Imidazole and benzimidazole caspase inhibitors and uses thereof
09/10/2003EP1341552A2 Treatment of immune-mediated diseases by oral administration of plasma fractions
09/10/2003EP1341551A2 Treatment of posterior capsule opacification
09/10/2003EP1341550A2 Method for treating respiratory distress syndrome
09/10/2003EP1341549A2 Combination therapy for estrogen-dependent disorders
09/10/2003EP1341548A2 METHODS FOR IDENTIFYING TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE CAUSED BY $g(b)-AMYLOID PEPTIDES
09/10/2003EP1341545A1 Bone putty and method
09/10/2003EP1341531A2 Lactam compound to inhibit beta-amyloid peptide release or synthesis
09/10/2003EP1341526A2 Pharmaceutical compositions for the oral delivery of pharmacologically active agents
09/10/2003EP1296948B1 Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
09/10/2003EP1253937B1 Use of thrombin derived peptides for the treatment of cardiovascular disorders
09/10/2003EP1203074A4 Compositions and methods for forming and strengthening bone
09/10/2003EP1189600B1 Grf-containing lyophilized pharmaceutical compositions
09/10/2003EP1179012B9 Long lasting fusion peptide inhibitors of viral infection
09/10/2003EP1165136B1 Combination therapy of angiotensin converting enzyme inhibitor and epoxy-steroidal aldosterone antagonist for treatment of cardiovascular disease
09/10/2003EP1157987B1 S-nitrosothiols as agents for the treatment of circulatory dysfunctions
09/10/2003EP1124572B1 Genes and proteins predictive and therapeutic for renal disease and associated disorders
09/10/2003EP1107813A4 Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers or covering structures
09/10/2003EP1096950B1 Therapies using hemoproteins
09/10/2003EP1053029B1 Sterile complex of therapeutic peptide bond to a polysaccharide
09/10/2003EP1047449B1 Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration
09/10/2003EP1007632A4 Isolation of bone and cartilage precursor cells
09/10/2003EP0981377B1 cOMPLEXES OF THE LHRH-ANTAGONIST CETRORELIX WITH POLY-AMINO ACIDS AND METHOD FOR THEIR PRODUCTION
09/10/2003EP0966483B1 Beta-endorphin peptides for treating muscle-wasting diseases
09/10/2003EP0948342B1 MEDICAL USES OF scuPA/suPAR COMPLEX
09/10/2003EP0906122B1 Activated linkers and methods for making and purifying the same
09/10/2003EP0871763A4 Method for preparation of type ii collagen
09/10/2003EP0783299B1 Compounds and compositions for delivering active agents
09/10/2003EP0772396B1 Method of regulating immune function
09/10/2003EP0689843B1 Composition containing soluble thrombomodulins
09/10/2003EP0594732B1 Humanized antibody against cd18
09/10/2003EP0575546B1 Cyclin d1 and its cdna
09/10/2003CN1441843A Extracellular matrix protein
09/10/2003CN1441841A Stimulation of cellular regeneration and differentiation in inner ear
09/10/2003CN1441810A Soluble CTL A4 mutant molecules and use thereof
09/10/2003CN1441809A Antifungal and/or antibacterial peptides, preparation methods and composition containing same
09/10/2003CN1441808A Chemokine receptor modulators, production and use
09/10/2003CN1441807A Hepatitis B core antigen fusion proteins
09/10/2003CN1441806A Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties
09/10/2003CN1441785A Tetrahydroixoquinoline analogs useful as growth hormone secretagogues
09/10/2003CN1441784A Thrombin inhibitors comprising aminoisoquinoline group
09/10/2003CN1441777A Inhibiting angiogenesis and tumor growth
09/10/2003CN1441680A Cyclodextrin containing glycopeptide antibiotic pharmaceutical compositions
09/10/2003CN1441677A Combined use of anti-cytokine antibodies or antagonists and anti-CD2O for treatment of B cell lymphoma
09/10/2003CN1441676A Method of treatment using ligand-immunogen conjugates
09/10/2003CN1441675A Compositions and methods for achieving immune suppression
09/10/2003CN1441670A Highly efficient delivery of large therapeutic mass aerosol
09/10/2003CN1441668A Compositions and methods to improve oral absorption of antimicrobial agents
09/10/2003CN1441666A Macromolecular drug complexes and compositions containing same
09/10/2003CN1441606A Method for establishing mobile station connection in cellular telecommunications system
09/10/2003CN1441057A Construction method of recombinant DNA expressing epidermal growth factor in animal's mammary gland
09/10/2003CN1440981A New-type recombinant tissue factor inhibiting peptide and its prepn and application
09/10/2003CN1440980A Mannosan peptide and its prepn and use
09/10/2003CN1440971A Vitronectin receptor antagnist, its preparation and use
09/10/2003CN1440816A Improvement for diagnosis and/or therapeutic agnet and its relative improvement
09/10/2003CN1440809A New use of neutral proteinase in treating burns
09/10/2003CN1440808A New use of neutral proteinase in treating hepatitis
09/10/2003CN1440807A Application of cyclosporin A in preparing anti-abortion medicine
09/10/2003CN1120725C Medicine for treating osteoporosis and hyperosteogeny and preparing process thereof
09/10/2003CN1120724C Stable liquid composition of gamma interferon
09/09/2003US6617438 Nucleic acid of given formula; ribozyme able to cleave RNA of HER2 gene; use as anticarcinogenic agent
09/09/2003US6617433 Of given amino acid sequence; can use for gene expression
09/09/2003US6617431 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses
09/09/2003US6617430 Ataxin-2 binding proteins
09/09/2003US6617428 Immunoglobulin M(IgM); given amino acid sequence; immunomodulators; use in blocking or inhibiting humoral immune responses in transplant patients
09/09/2003US6617426 Peptide analogs of given formula; useful in treating neurodegenerative, autoimmune, cognitive disorders, stroke and traumatic injury
09/09/2003US6617423 Lactam bridge between aspartic acid and orinithine; increased conformational stability; useful in treatment of osteoporosis, Paget's disease or hypercalcemia
09/09/2003US6617354 Method of stabilizing and potentiating the action of anti-angiogenic substances
09/09/2003US6617345 Cyclooxygenase-2 inhibitor is (5-bromo-2-(4-fluorophenyl )-3-(4-(methylsulfonyl)phey)-thiophene), N-(2-(cyclohexyloxy 4-nitrophenyl)-methanesulfonamide), meloxicam, flosulide or cyclic substituted phenyl sulfones or sulfonamides
09/09/2003US6617320 Protease inhibitor; anticoagulants
09/09/2003US6617317 Boronic ester and acid compositions
09/09/2003US6617312 Contains a sequence motif selected from the group consisting of the motifs (Asp or Glu)-Ala-Trp-(Lys or Arg) or (Tyr or Cys)-(Glu or Asp)-(Leu or Ile)-Trp; binds to vasoactive amines such as histamine
09/09/2003US6617311 Effecting an increase in the amount of TH within the CNS through increasing the effective amount of an analog of Gly-Pro-Glu tripeptide (GPE) within the CNS of said patient; analog may be GP or PE. t
09/09/2003US6617310 Phosphate esters of bis-amino acid sulfonamides containing substituted benzyl amines
1 ... 1775 1776 1777 1778 1779 1780 1781 1782 1783 1784 1785 1786 1787 1788 1789 1790 1791 1792 1793 1794 1795 ... 3163